Literature DB >> 19605746

Optimalization of the clinical pharmacogenetic model to predict methotrexate treatment response: the influence of the number of haplotypes of MTHFR 1298A-677C alleles on probability to respond.

W M Kooloos, J A M Wessels, S M van der Kooij, C F Allaart, T W J Huizinga, H-J Guchelaar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19605746     DOI： 10.1136/ard.2008.096891

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

Review 1.  Leveraging human genetics to develop future therapeutic strategies in rheumatoid arthritis.

Authors:  Robert M Plenge; Soumya Raychaudhuri
Journal:  Rheum Dis Clin North Am       Date:  2010-05       Impact factor: 2.670

Review 2.  Genetic and epigenetic predictors of responsiveness to treatment in RA.

Authors:  Darren Plant; Anthony G Wilson; Anne Barton
Journal:  Nat Rev Rheumatol       Date:  2014-02-18       Impact factor: 20.543

Review 3.  The Potential Role of Genomic Medicine in the Therapeutic Management of Rheumatoid Arthritis.

Authors:  Marialbert Acosta-Herrera; David González-Serna; Javier Martín
Journal:  J Clin Med       Date:  2019-06-10       Impact factor: 4.241

4.  TNF-α Polymorphisms in Juvenile Idiopathic Arthritis: Which Potential Clinical Implications?

Authors:  A Scardapane; L Breda; M Lucantoni; F Chiarelli
Journal:  Int J Rheumatol       Date:  2012-10-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.